Extraordinary Publication Use Patents Linkage Gazette

On October 30 it was published, an extraordinary edition of the Mexican Patent Linkage System’s Gazette on allopathic medicines, including patents containing the so-called use claims.

At OLIVARES, we are reviewing this publication. Anyhow, this seems to be a very good news and an important achievement after the strong policy efforts of the innovative pharmaceutical industry in Mexico, through various associations and for not giving up on filing legal actions against the exclusion and lack of observance for these types of use claims. It is also a recognition of the Mexican government, specifically the Mexican Institute of Industrial Property IMPI, for adhering to the international framework of broad protection of industrial property rights, as contemplated in various international provisions and commitments.

We will continue to analyze the development and operation of the linkage system and keep you updated.

FOR FURTHER INFORMATION ON THE CONTENT OF THIS NEWSLETTER, PLEASE CONTACT:

Gustavo Alcocer

Partner

Gustavo Alcocer manages the Corporate and Commercial Law Group at OLIVARES, advising domestic and foreign businesses and the owners of those businesses on Mexican and cross-border corporate and commercial transactions.

Alejandro Luna F.

Partner

Alejandro Luna joined OLIVARES in 1996 and being made partner in 2005, he has been instrumental to the firm’s IP Litigation, Regulatory, and Administrative Litigation practices. He co-chairs the Life Sciences & Pharmaceutical Law industry group and coordinates the Litigation Department.

Armando Arenas

Partner

Armando Arenas joined OLIVARES in 2000 and became a partner in January 2017. He has experience working on a range of IP matters, including consulting and litigation on trademark, patent, unfair competition, trade dress protection, and misleading advertising cases before the Mexican Institute of Industrial Property (IMPI), Federal Court of Tax and Administrative Affairs (FCTA), Federal Circuit Courts (FCC) and the Supreme Court of Justice (SCJ) Regulatory Affairs and Public Acquisitions.

ASSOCIATES

WHO CAN BE FOUND AT THE FOLLOWING NUMBER:

+52(55) 5322 3000

Newsletters - Patents

Return...